Home > Offer to Sell > Pharmaceuticals and Biochemicals > Others > Supply Aromatase Inhibitor Estrogen Powder Letrozoles Femara CAS: 112809-51-5
Supply Aromatase Inhibitor Estrogen Powder Letrozoles Femara CAS: 112809-51-5
Inquiry
| Post Date: | Mar 23,2017 |
| Expiry Date: | Mar 23,2018 |
| Detailed Description: |
Cas No. :112809-51-5
Quantity: 1000Kilograms Specs:white powder Price:10 USD Kilograms Payment Method: T/T,Western Union,Moneygram, Letrozole description: Femara is a powerful Aromatase Inhibitor that was developed to fight breast cancer. For athletes and bodybuilders, it is a drug used to combat the estrogenic side effects of anabolic steroids water-retention, acne and gynocomastia. It will also raise testosterone levels because of the lowered estrogen in the body. Side effects from include a lowered sex drive and continuous use can lead to lowered lipid function and an impaired immune system. Femara is intended for use only by women who are no longer of childbearing age. Possible candidates must have already ceased to menstruate. It is often used in patients who have already undergone other cancer treatments, such as radiation, chemotherapy, and used other cancer drugs, like tamoxifen. This nonsteroidal aromatase inhibitor may help prevent any remaining cancer cells from spreading. Femara is used for the treatment of post-menopause breast cancer. Letrozole (Steroids) basic info. Femara Anti-Estrogen Powder Letrozole Alias: Femara CAS NO.: 112809-51-5 Molecular Formula: C17H11N5 Molecular Weight: 285.31 White or light yellow crystal Method of Analysis: HPLC Standard: USP/BP Usage: Used as API in Treatment of breast disease. Effect: letrozole in postmenopausal patients with advanced breast cancer whose Estrogen receptor and / or progesterone receptor positive or receptor status unknown Femara (letrozole) is a type II (non-steroidal) third generation aromatase inhibitor. Clinically it is used to treat postmenopausal women with either estrogen receptor positive or estrogen receptor unknown breast cancer. 1. Letrozole is a powerful Aromatase Inhibitor that was developed to fight breast cancer. 2. For athletes and bodybuilders, it is a drug used to combat the estrogenic side effects of anabolic steroids water-retention, acne and gynocomastia. 3. It will also raise testosterone levels because of the lowered estrogen in the body. 4. Femara(generic name is letrozole) is a new drug developed for the treatment of advanced breast cancer in women. 5. Femara is the second in a new class of third-generation selective oral aromatase inhibitors. 6. It acts by blocking the enzyme aromatase, subsequently blocking the production of estrogen. |
| CAS Registry Number: | 112809-51-5 |
| Synonyms: | ;4,4'-(1h-1,2,4-Triazol-1-Ylmethylene)Bisbenzonitrile;Lelrozol;4,4'-(1h-1,2,4-Triazol-1-Ylmethylene) Bis-Benzonitrile;Femara;Letrozol;Letrazole; |
| Molecular Formula: | C17H11N5 |
| Molecular Weight: | 285.31 |
| Molecular Structure: | 
|
| Company: | China yuancheng technoloty wuhan branch ltd. [ China ] |
| Contact: | Kathelin |
| Tel: | 86-27-6888669 |
| Fax: | |
| Email: | kathelin@chembj.com |
-
Disclaimer statement:The information and data included above have been realized by the enterprises and compiled by the staff, and are subject to change without notice to you. The Chemnet makes no warranties or representations whatsoever regarding the facticity, accuracy and validity of such information and data. In order to ensure your interest, we suggest you chose the products posted by our gold suppliers or VIP members.
